Crescent Biopharma CMO Ellie Eunkyung Im Sells $11.2K of Stock
Ellie Eunkyung Im, CMO, sold 623 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.2K in total on Sep 16, 2026. Shares held after the trade: 21,446 (-2.8%).
Crescent Biopharma President and COO Jonathan McNeill Sells $77.2K of Stock
Jonathan McNeill, President and COO, sold 4,570 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.90) in 2 transactions, worth $77.2K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 134,588 (-2.8%).
Crescent Biopharma CFO Richard William Scalzo Sells $10.2K of Stock
Richard William Scalzo, CFO, sold 568 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $10.2K in total on Sep 16, 2026. Shares held after the trade: 19,730 (-2.8%).
Crescent Biopharma CEO Joshua T. Brumm Sells $160K of Stock
Joshua T. Brumm, CEO, sold 9,447 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.91) in 2 transactions, worth $160K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 271,765 (-2.8%).
Crescent Biopharma Insider Barbara Harlin Bispham Sells $11.1K of Stock
Barbara Harlin Bispham sold 620 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.1K in total on Sep 16, 2026. Shares held after the trade: 18,710 (-3.2%).